ExodusPoint Capital Management’s Claritev CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Buy
13,048
+5,224
+67% +$165K ﹤0.01% 1457
2026
Q2
$267K Buy
+7,824
New +$192K ﹤0.01% 1384
2022
Q1
– Sell
-816
Closed -$145K – 2752
2021
Q4
$145K Sell
816
-1,233
-60% -$220K ﹤0.01% 1890
2021
Q3
$461K Buy
2,049
+707
+53% +$191K 0.01% 1444
2021
Q2
$511K Sell
1,342
-16,708
-93% -$5.18M 0.01% 1381
2021
Q1
$4.01M Buy
+18,050
New +$5.2M 0.06% 344
2020
Q4
– Sell
-878
Closed -$360K – 2462
2020
Q3
$360K Buy
+878
New +$386K 0.01% 1194

Other funds holding CTEV

ExodusPoint Capital Management's CTEV Position: Q3 2026 in Review

ExodusPoint Capital Management increased its Claritev (CTEV) stake by 67% in Q3 2026, buying an estimated $165K and bringing the position to 13,048 shares worth $276K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

ExodusPoint Capital Management first reported a position in CTEV in Q3 2020 and has held it in 7 quarters since. The position peaked at $4.01M in Q1 2021. 106 funds tracked by Wall St. Rank hold CTEV as of Q3 2026.

  • ExodusPoint Capital Management held 13,048 shares of Claritev worth $276K as of Q3 2026.
  • ExodusPoint Capital Management bought 5,224 Claritev shares in Q3 2026, an estimated $165K.
  • Claritev made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q3 2026, its #1457 holding.
  • ExodusPoint Capital Management first reported a position in Claritev in Q3 2020 and has held it in 7 quarters since.
  • ExodusPoint Capital Management's Claritev position peaked at $4.01M in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Claritev as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.